Kevin Kotler

Insider Reports History

Entity
Individual
Location
C/O Broadfin Capital, Llc, 300 Park Avenue, 25 Th Floor, New York, NY
Signature
/s/ Lisa Peraza Attorney-in-fact for Kevin Kotler
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Kotler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HERON THERAPEUTICS, INC. /DE/ Director Common Stock 540K $1.16M $2.15 Feb 22, 2023 By Broadfin Holdings LLC
HERON THERAPEUTICS, INC. /DE/ Director Common Stock 37.9K $81.4K $2.15 Feb 22, 2023 Direct
BIODELIVERY SCIENCES INTERNATIONAL INC Director Common Stock 0 $1.80 Mar 22, 2022 Indirect
BIODELIVERY SCIENCES INTERNATIONAL INC Director Restricted Stock Units 0 Mar 22, 2022 Indirect
BIODELIVERY SCIENCES INTERNATIONAL INC Director Stock Options (right to buy) 0 $2.93 Mar 22, 2022 Indirect

Insider Reports Filed by Kevin Kotler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HRTX HERON THERAPEUTICS, INC. /DE/ Feb 22, 2023 0 $0 3 Mar 2, 2023 Director
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC Mar 22, 2022 4 $0 4 Mar 22, 2022 Director
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC Feb 11, 2022 2 $0 4 Feb 15, 2022 Director
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC Jan 27, 2022 4 $0 4 Jan 31, 2022 Director
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC Nov 19, 2021 1 $306K 4 Nov 22, 2021 Director
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC Nov 12, 2021 1 $320K 4 Nov 15, 2021 Director
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC Nov 5, 2021 1 $895K 4 Nov 9, 2021 Director
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC Aug 6, 2021 4 $87.9K 4 Aug 10, 2021 Director
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC May 11, 2021 3 $961K 4 May 13, 2021 Director